News | Proton Therapy | April 13, 2016

UF Health Cancer Center-Orlando Health Begins Proton Therapy Treatments

Center uses Mevion S250 system supplied by American Shared Hospital Services

Mevion S250, proton therapy, UF Health Cancer Center Orlando Health, American Shared Hospital Services

April 13, 2016 — Physicians have begun treating patients with the Mevion S250 proton therapy system at The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center-Orlando Health in Florida. The system was supplied by American Shared Hospital Services, provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services.

Proton therapy is an external-beam radiation therapy technique similar to conventional high-energy X-rays. The difference is that protons are heavy charged particles that deposit radiation in a targeted manner — when they reach a specific depth, protons deposit their energy and then stop, leaving virtually no energy beyond that depth. The depth is precisely controlled by changing the energy of the protons, thus allowing physicians to precisely tailor the proton dose to the specific depth and shape of the tumor, and thereby greatly reducing the dose to surrounding healthy tissue. Only 21 proton centers are in operation in the United States today.

The Marjorie and Leonard Williams Center for Proton Therapy is housed in a new 15,000 square foot facility consisting of three floors — two above ground and one underground — to accommodate the Mevion S250 superconducting synchrocyclotron proton accelerator.

For more information: www.mevion.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.